210 related articles for article (PubMed ID: 15081192)
21. Striving for quality use of medicines: how effective is Australia's ban on direct-to-consumer prescription medicine advertising?
Brown S
J Law Med; 2009 Feb; 16(4):666-83. PubMed ID: 19297873
[TBL] [Abstract][Full Text] [Related]
22. The draft pharmaceutical policy: the weakest link.
Desrosiers G
Perspect Infirm; 2005; 2(4):8-11. PubMed ID: 15816423
[No Abstract] [Full Text] [Related]
23. Pricing and reimbursement of pharmaceuticals in Italy.
Folino-Gallo P; Montilla S; Bruzzone M; Martini N
Eur J Health Econ; 2008 Aug; 9(3):305-10. PubMed ID: 18566845
[TBL] [Abstract][Full Text] [Related]
24. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
Rai AK
Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
[TBL] [Abstract][Full Text] [Related]
25. Partnerships in primary care in Australia: network structure, dynamics and sustainability.
Lewis JM; Baeza JI; Alexander D
Soc Sci Med; 2008 Jul; 67(2):280-91. PubMed ID: 18472201
[TBL] [Abstract][Full Text] [Related]
26. Generics market in Greece: the pharmaceutical industry's beliefs.
Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
[TBL] [Abstract][Full Text] [Related]
27. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
28. Historical development of health technology assessment in Thailand.
Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
[TBL] [Abstract][Full Text] [Related]
29. The Pharmaceutical Benefits Scheme and the shifting paradigm of welfare policy.
Löfgren H
Aust Health Rev; 1998; 21(2):111-23. PubMed ID: 10181679
[TBL] [Abstract][Full Text] [Related]
30. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
Hanley GE; Morgan S; Hurley J; van Doorslaer E
Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
[TBL] [Abstract][Full Text] [Related]
31. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
Chodock R; Yolkut D; Connolly DR
Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
[TBL] [Abstract][Full Text] [Related]
32. Using national health policies to improve access to palliative care medications in the community.
Rowett D; Ravenscroft PJ; Hardy J; Currow DC
J Pain Symptom Manage; 2009 Mar; 37(3):395-402. PubMed ID: 18722748
[TBL] [Abstract][Full Text] [Related]
33. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
[TBL] [Abstract][Full Text] [Related]
34. Translating an adolescent smoking cessation program into policy and practice in an Australian context.
Cross D; Hearn L; Hamilton G; Resnicow K; Hall M
Eval Health Prof; 2008 Sep; 31(3):245-57. PubMed ID: 18559881
[TBL] [Abstract][Full Text] [Related]
35. Worrying times for Medicare.
Armstrong F
Aust Nurs J; 2003 Jun; 10(11):28-30. PubMed ID: 18567388
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation for pharmaceuticals in Germany.
Jönsson B
Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
[No Abstract] [Full Text] [Related]
37. An historical overview of Australia's largest and oldest provider of vocational rehabilitation--CRS Australia.
O'Halloran D
Work; 2002; 19(3):211-8. PubMed ID: 12547966
[TBL] [Abstract][Full Text] [Related]
38. Medicines regulation and health technology assessment.
Breckenridge A; Woods K; Walley T
Clin Pharmacol Ther; 2010 Feb; 87(2):152-4. PubMed ID: 20107448
[TBL] [Abstract][Full Text] [Related]
39. Access to new medicines in New Zealand compared to Australia.
Wonder M; Milne R
N Z Med J; 2011 Nov; 124(1346):12-28. PubMed ID: 22143849
[TBL] [Abstract][Full Text] [Related]
40. Supervision in social health insurance: a four country study.
Maarse H; Paulus A; Kuiper G
Health Policy; 2005 Mar; 71(3):333-46. PubMed ID: 15694500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
